« back


Luisa Salter-Cid, Ph.D. currently serves as the Chief Scientific Officer of Gossamer Bio where she oversees a Research team focused on bringing Immunology-based innovative medicines up to IND filling. Prior to joining Gossamer, Dr. Salter-Cid spent 13 years at Bristol Myers Squibb where she held several positions including Vice President and Head of Immunology, small molecule Immuno-Oncology and Genomics Discovery. In this position, she oversaw several biology groups that focused on target validation and development of innovative biologic and small-molecule therapeutics to address significant unmet needs in autoimmune diseases and cancer. During her time at BMS, Dr. Salter-Cid led teams that advanced more than 20 compounds into clinical development. She was also Chair of the Immunoscience Target Science Team (TST) and a core member of several executive committees focused on strategy, development and external collaborations. Prior to joining BMS, she was a Senior Project Leader at La Jolla Pharmaceuticals where she led discovery projects. She also held positions at Genset Corp and Johnson & Johnson.